Pharmafile Logo
Pharmafocus logo
Advanced Search

New partner drives Simon-Kucher’s Life Sciences growth in the UK

November 19, 2015
Medical Communications

The global strategy and marketing consultancy Simon-Kucher & Partners has appointed eleven new partners for 2016, with eight of them …

Appointment
lyrica_advert

American Medical Association calls for ban on drug commercials

November 19, 2015
Medical Communications, Sales and Marketing

The American Medical Association (AMA) has called for a ban on the promotion of prescription products; action which it believes …

News
nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015
Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …

News

Physicians Interactive becomes Aptus Health, offering a global digital health engagement solution

November 19, 2015
Medical Communications

Physicians Interactive has announced that it has become Aptus Health, reflecting its mission of advancing health engagement and its role …

News
Press release
bayer_cross_2

NICE decision restricts Bayer’s Xofigo to select prostate cancer patients

November 19, 2015
Research and Development, Sales and Marketing Bayer, NICE, prostate cancer

NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …

News
fda_sign_web

FDA grants Merck and Pfizer priority review for PD-L1 cell treatment

November 19, 2015

The FDA has granted Merck and Pfizer’s avelumab Breakthrough Therapy Designation for the treatment of patients with metastatic merkel cell …

News
nice

Merck criticises NICE ‘no’ to personalised bowel cancer drugs

November 19, 2015
Research and Development

NICE has issued preliminary not recommending two specific personalised treatments used in combination with chemotherapy for previously untreated metastatic colorectal …

News
Merck

Merck KGaA completes $17bn Sigma-Aldrich acquisition

November 18, 2015
Manufacturing and Production, Sales and Marketing M&A Sigma Aldridge, Merck, acquisitions, mergers

Merck KGaA has announced the completion of its $17 billion acquisition of Sigma-Aldrich, having cleared the final regulatory hurdle and …

News
US Capitol building

Obama FDA commissioner nominee Califf defends big pharma ties

November 18, 2015
Sales and Marketing Bernie Sanders, FDA, FDA commissioner, Robert Califf

President Obama’s nominee to head the FDA was forced to defend his history of ties to the pharma industry as …

News

Raising Awareness: World COPD Day

November 18, 2015
Medical Communications COPD, COPD disease, COPD exacerbation, Synergy Vision, disease awareness, medical communications

World COPD Day 18th November 2015

Feature
Thought Leadership

NICE rejects Amgen’s Repatha in draft guidance

November 18, 2015
Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol

NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.   

News
Takeda oncology

Challenges in oncology R&D

November 18, 2015
Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …

Feature
FDA sign

FDA accepts regulatory submission for Novartis biosimilar

November 18, 2015
Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim

Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …

News
pills

Global drug spending will rise 30% by 2020, to $1.4 trillion

November 18, 2015
Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing

Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …

News
Researcher

Scientists make possible pancreatic cancer discovery

November 18, 2015
Research and Development Pancreatic cancer

Cancer researchers say they have discovered a potential new method of treatment for pancreatic cancer that could improve survival rates.  …

News
steve_turley_linkedin

UCB appoints Steve Turley as MD for Britain and Ireland

November 18, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB

Steve Turley has joined UCB as the company’s managing director for the British and Irish isles, moving from Lundbeck. He …

Appointment
Norgine logo

Norgine opens new £4.5 million warehouse

November 17, 2015
Manufacturing and Production, Research and Development Norgine, Temperature control, Wales, manufacturing, production, temperature-control

Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales.  The Dutch-based firm …

News
dr_kevin_johnson_-_chairman

Crescendo Biologics appoints Dr Kevin Johnson as chairman

November 17, 2015
Research and Development

Crescendo Biologics, the drug discovery and developer of Humabody VH therapeutics, has announced the appointment of Dr Kevin Johnson as non-executive …

Appointment
catalent_logo

Catalent forced to suspend production after possible employee product sabotage

November 17, 2015
Manufacturing and Production

Catalent has been forced to halt production at one of its French softgel capsule factories after the US-based manufacturer identified …

News
abbvie_0

AbbVie rules out joining the biosimilars bandwagon

November 17, 2015
Manufacturing and Production, Research and Development

AbbVie says it has ruled out moving into the biosimilars market to stave off competition once its blockbuster drug Humira …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026